These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19890014)

  • 21. Memory impairment in abstinent MDMA ("Ecstasy") users.
    Bolla KI; McCann UD; Ricaurte GA
    Neurology; 1998 Dec; 51(6):1532-7. PubMed ID: 9855498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.
    Daumann J; Fimm B; Willmes K; Thron A; Gouzoulis-Mayfrank E
    Brain Res Cogn Brain Res; 2003 May; 16(3):479-87. PubMed ID: 12706227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
    Daumann J; Schnitker R; Weidemann J; Schnell K; Thron A; Gouzoulis-Mayfrank E
    Neuroreport; 2003 Oct; 14(15):1983-7. PubMed ID: 14561934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users.
    Croft RJ; Klugman A; Baldeweg T; Gruzelier JH
    Am J Psychiatry; 2001 Oct; 158(10):1687-92. PubMed ID: 11579003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecstasy (MDMA): a review of its possible persistent psychological effects.
    Morgan MJ
    Psychopharmacology (Berl); 2000 Oct; 152(3):230-48. PubMed ID: 11105933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
    Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
    Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecstasy': evidence for cognitive impairment.
    Bhattachary S; Powell JH
    Psychol Med; 2001 May; 31(4):647-58. PubMed ID: 11352367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
    Reneman L; Lavalaye J; Schmand B; de Wolff FA; van den Brink W; den Heeten GJ; Booij J
    Arch Gen Psychiatry; 2001 Oct; 58(10):901-6. PubMed ID: 11576026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Syllogistic reasoning performance in MDMA (Ecstasy) users.
    Montgomery C; Fisk JE; Newcombe R; Wareing M; Murphy PN
    Exp Clin Psychopharmacol; 2005 May; 13(2):137-45. PubMed ID: 15943546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
    Potter A; Downey L; Stough C
    Curr Drug Abuse Rev; 2013 Mar; 6(1):71-6. PubMed ID: 23259912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge.
    Taffe MA; Davis SA; Yuan J; Schroeder R; Hatzidimitriou G; Parsons LH; Ricaurte GA; Gold LH
    Neuropsychopharmacology; 2002 Dec; 27(6):993-1005. PubMed ID: 12464456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
    Curran HV; Verheyden SL
    Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep.
    Allen RP; McCann UD; Ricaurte GA
    Sleep; 1993 Sep; 16(6):560-4. PubMed ID: 7901886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of genetic and environmental factors among MDMA users in cognitive performance.
    Cuyàs E; Verdejo-García A; Fagundo AB; Khymenets O; Rodríguez J; Cuenca A; de Sola Llopis S; Langohr K; Peña-Casanova J; Torrens M; Martín-Santos R; Farré M; de la Torre R
    PLoS One; 2011; 6(11):e27206. PubMed ID: 22110616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.
    Roberts CA; Quednow BB; Montgomery C; Parrott AC
    Neurosci Biobehav Rev; 2018 Jan; 84():470-482. PubMed ID: 28801175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.